Skip to content
OpenCapital
Get started

Globus Medical GMED Reportable Segment — Research and Development Employee Related Costs

Similar metrics at other companies

Insmed logo
INSMReportable Segment — R&D compensation and benefit-related expenses
$72.14M+34.7%
Madrigal Pharmaceuticals, Inc. logo
MDGLReportable Segment — Research ​And ​Development​ Expense, Personnel And Internal
$22.17M+3.2%
Madrigal Pharmaceuticals, Inc. logo
MDGLReportable Segment — Research and Development External Expense
$94.09M+2,166%
Guardant Health logo
GHReportable Segment — Research and development expense
$76.59M+2.3%
Amgen logo
AMGNReportable Segment — R&D
$1.72B+15.7%
Biogen logo
BIIBReportable Segment — Research and development:
$172.8M-3.2%

Other financials

Income statement

See full
Revenue$759.9M+27.0%
Gross profit$525.8M+30.6%
Operating income$150.4M+55.0%
Net income$124.3M+64.7%
EPS (diluted)$0.90+66.7%

Balance sheet

See full
Cash & equivalents$561.0M+21.6%
Total debt$116.3M+25.0%
Total equity$4.7B+15.8%
Total assets$5.4B+15.5%

Cash flow

See full
Operating cash flow$202.4M+14.1%
CapEx$39.6M+9.7%
Free cash flow$162.7M+15.3%

Valuation

See full
Market cap$10.76B+15.7%
Enterprise value$10.31B+15.6%
P/E18.3×-31.7×
P/S3.5×-0.2×

Profitability

See full
Gross margin67.9%+7.3pp
Operating margin17.2%+7.0pp
Net margin18.9%+11.5pp
FCF margin19.7%-1.1pp

Returns & leverage

See full
Return on equity13.3%+8.7pp
Debt / equity0×0.0×
Current ratio4.6×+0.1×

Where this comes from

Reported directly by Globus Medical in its filing.

Tagged under the XBRL concept gmed:ResearchAndDevelopmentEmployeeRelatedCosts.

The official record: Globus Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Globus Medical's reportable segment — research and development employee related costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Globus Medical's reportable segment — research and development employee related costs?
Globus Medical (GMED) reported reportable segment — research and development employee related costs of $27.34M in Q1 2026.
How has Globus Medical's reportable segment — research and development employee related costs changed year-over-year?
Globus Medical's reportable segment — research and development employee related costs increased by 7.5% year-over-year, from $25.43M to $27.34M.
What does reportable segment — research and development employee related costs mean?
The total payroll and benefit costs for staff dedicated to research and development.
How do you interpret reportable segment — research and development employee related costs?
An increase reflects investment in future innovation, while a decrease may suggest cost-cutting or a shift in R&D strategy.
How does reportable segment — research and development employee related costs compare across companies?
Standard R&D personnel expense metric for technology-driven medical device companies.